Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes
/in Cervical Cancer, Dendritic Cells, Exosome, International Publications /von 2018-02-08 / Int. J. Biol. Macromol. 2018 Jul;113:1182-1187Myeloid and plasmacytoid dendritic cell vaccinations for castration-resistant prostate cancer patients.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2018-02-08 / J Clin Oncol 36, 2018 (suppl 6S; abstr 219)Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
/in Dendritic Cells, International Publications /von 2018-02-01 / Trends Cancer 2018 02;4(2):119-137Radiation and Anti-Cancer Vaccines: A Winning Combination
/in Dendritic Cells, International Publications /von 2018-01-30 / Vaccines (Basel) 2018 Jan;6(1)Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8 T cell activation in the presence of adjuvant temozolomide
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-01-29 / Oncoimmunology 2018;7(4):e1412901Autologous tumor lysate-pulsed dendritic cell vaccination therapy after resection of stage IIA (T2N0, T3N0) esophageal cancer: An analysis of immunological responses.
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2018-01-26 / J Clin Oncol 36, 2018 (suppl 5S; abstr 96)A prospective, randomized, blinded, placebo-controlled, phase IIb trial of an autologous tumor lysate + yeast cell wall particles (YCWP) + dendritic cells (DC) vaccine vs unloaded YCWP + DC and embedded phase I/IIa trial with tumor lysate particle only (TLPO) vaccine in stage III and stage IV (resected) melanoma to prevent recurrence.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-01-25 / J Clin Oncol 36, 2018 (suppl 5S; abstr TPS201)A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2018-01-10 / Oncotarget 2018 Feb;9(11):10110-10117EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2018-01-03 / PLoS ONE 2018;13(1):e0190638
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de